Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags — Oct 18th, 2024

Elevance Health (NYSE:ELV) Third Quarter 2024 Results Key Financial Results Revenue: US$45.1b (up 5.3% from 3Q 2023). Net income: US$1.02b (down 21% from 3Q 2023). Profit margin: 2.3% (down from 3.0% in 3Q 2023). The decrease in margin was driven by higher expenses. EPS: US$4.36 (down fr...

Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags — Oct 18th, 2024

Elevance Health (NYSE:ELV) Third Quarter 2024 Results Key Financial Results Revenue: US$45.1b (up 5.3% from 3Q 2023). Net income: US$1.02b (down 21% from 3Q 2023). Profit margin: 2.3% (down from 3.0% in 3Q 2023). The decrease in margin was driven by higher expenses. EPS: US$4.36 (down fr...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

AP Top Extended Financial Headlines at 4:04 a.m. EDT — Oct 18th, 2024

Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its third quarter View comments...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity — Oct 18th, 2024

For Immediate Release Chicago, IL – October 18, 2024 – Today, Zacks Equity Research discusses Elevance Health, Inc. ELV, Doximity DOCS and HealthEquity HQY. Industry: Medical Services Link: https://www.zacks.com/commentary/2352203/3-medical-services-stocks-to-buy-to-navigate-industr...

Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity — Oct 18th, 2024

For Immediate Release Chicago, IL – October 18, 2024 – Today, Zacks Equity Research discusses Elevance Health, Inc. ELV, Doximity DOCS and HealthEquity HQY. Industry: Medical Services Link: https://www.zacks.com/commentary/2352203/3-medical-services-stocks-to-buy-to-navigate-industr...

Elevance Health Inc (ELV) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Medicaid Challenges — Oct 18th, 2024

Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Opera...

Elevance Health Inc (ELV) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Medicaid Challenges — Oct 18th, 2024

Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Opera...

Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags — Oct 18th, 2024

Elevance Health (NYSE:ELV) Third Quarter 2024 Results Key Financial Results Revenue: US$45.1b (up 5.3% from 3Q 2023). Net income: US$1.02b (down 21% from 3Q 2023). Profit margin: 2.3% (down from 3.0% in 3Q 2023). The decrease in margin was driven by higher expenses. EPS: US$4.36 (down fr...

Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight — Oct 18th, 2024

Comprehensive SWOT analysis based on the latest 10-Q SEC filing. Financial performance highlights and strategic positioning of Elevance Health Inc. Expert breakdown of strengths, weaknesses, opportunities, and threats facing the company. Warning! GuruFocus has detected 4 Warning Signs wit...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

AP Top Extended Financial Headlines at 4:04 a.m. EDT — Oct 18th, 2024

Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its third quarter View comments...

Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight — Oct 18th, 2024

Comprehensive SWOT analysis based on the latest 10-Q SEC filing. Financial performance highlights and strategic positioning of Elevance Health Inc. Expert breakdown of strengths, weaknesses, opportunities, and threats facing the company. Warning! GuruFocus has detected 4 Warning Signs wit...

Elevance Health Inc (ELV) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Medicaid Challenges — Oct 18th, 2024

Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Opera...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Elevance Health Inc (ELV) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Medicaid Challenges — Oct 18th, 2024

Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Opera...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity — Oct 18th, 2024

For Immediate Release Chicago, IL – October 18, 2024 – Today, Zacks Equity Research discusses Elevance Health, Inc. ELV, Doximity DOCS and HealthEquity HQY. Industry: Medical Services Link: https://www.zacks.com/commentary/2352203/3-medical-services-stocks-to-buy-to-navigate-industr...

Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags — Oct 18th, 2024

Elevance Health (NYSE:ELV) Third Quarter 2024 Results Key Financial Results Revenue: US$45.1b (up 5.3% from 3Q 2023). Net income: US$1.02b (down 21% from 3Q 2023). Profit margin: 2.3% (down from 3.0% in 3Q 2023). The decrease in margin was driven by higher expenses. EPS: US$4.36 (down fr...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity — Oct 18th, 2024

For Immediate Release Chicago, IL – October 18, 2024 – Today, Zacks Equity Research discusses Elevance Health, Inc. ELV, Doximity DOCS and HealthEquity HQY. Industry: Medical Services Link: https://www.zacks.com/commentary/2352203/3-medical-services-stocks-to-buy-to-navigate-industr...

Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight — Oct 18th, 2024

Comprehensive SWOT analysis based on the latest 10-Q SEC filing. Financial performance highlights and strategic positioning of Elevance Health Inc. Expert breakdown of strengths, weaknesses, opportunities, and threats facing the company. Warning! GuruFocus has detected 4 Warning Signs wit...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity — Oct 18th, 2024

For Immediate Release Chicago, IL – October 18, 2024 – Today, Zacks Equity Research discusses Elevance Health, Inc. ELV, Doximity DOCS and HealthEquity HQY. Industry: Medical Services Link: https://www.zacks.com/commentary/2352203/3-medical-services-stocks-to-buy-to-navigate-industr...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

AP Top Extended Financial Headlines at 4:04 a.m. EDT — Oct 18th, 2024

Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its third quarter View comments...

Elevance Health Inc (ELV) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Medicaid Challenges — Oct 18th, 2024

Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Opera...

Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags — Oct 18th, 2024

Elevance Health (NYSE:ELV) Third Quarter 2024 Results Key Financial Results Revenue: US$45.1b (up 5.3% from 3Q 2023). Net income: US$1.02b (down 21% from 3Q 2023). Profit margin: 2.3% (down from 3.0% in 3Q 2023). The decrease in margin was driven by higher expenses. EPS: US$4.36 (down fr...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

AP Top Extended Financial Headlines at 4:04 a.m. EDT — Oct 18th, 2024

Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its third quarter View comments...

Elevance Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags — Oct 18th, 2024

Elevance Health (NYSE:ELV) Third Quarter 2024 Results Key Financial Results Revenue: US$45.1b (up 5.3% from 3Q 2023). Net income: US$1.02b (down 21% from 3Q 2023). Profit margin: 2.3% (down from 3.0% in 3Q 2023). The decrease in margin was driven by higher expenses. EPS: US$4.36 (down fr...

Elevance Health Inc (ELV) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Medicaid Challenges — Oct 18th, 2024

Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Opera...

Q3 2024 Elevance Health Inc Earnings Call — Oct 18th, 2024

Participants Stephen Tanal; Vice President - Investor Relations; Elevance Health Inc Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice Presi...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Elevance Health Inc (ELV) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Medicaid Challenges — Oct 18th, 2024

Adjusted Diluted Earnings Per Share (EPS): $8.37 for Q3 2024, below expectations. GAAP Diluted EPS: $4.36 for Q3 2024. Total Operating Revenue: $44.7 billion, up over 5% year-over-year. Benefit Expense Ratio: 89.5% for Q3 2024, an increase of 270 basis points year-over-year. Adjusted Opera...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity — Oct 18th, 2024

For Immediate Release Chicago, IL – October 18, 2024 – Today, Zacks Equity Research discusses Elevance Health, Inc. ELV, Doximity DOCS and HealthEquity HQY. Industry: Medical Services Link: https://www.zacks.com/commentary/2352203/3-medical-services-stocks-to-buy-to-navigate-industr...

Centene Stock Rallies After Strong Earnings, Medicaid Comments — Oct 25th, 2024

Centene shares rose sharply after it reassured investors that a financial squeeze in its Medicaid business would soon ease as it negotiates higher payment rates from the program. The company became the latest insurer to report strong earnings while contending with higher medical costs, a d...

Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight — Oct 18th, 2024

Comprehensive SWOT analysis based on the latest 10-Q SEC filing. Financial performance highlights and strategic positioning of Elevance Health Inc. Expert breakdown of strengths, weaknesses, opportunities, and threats facing the company. Warning! GuruFocus has detected 4 Warning Signs wit...